Biopharmaceutical - Related Information

Simplified Mass Measurement of Chemically-Modified Antibodies: Determination of the Presence of theNumber of Modifications Using a Linear BenchtopMALDI-TOF MS - MALDI-TOF Mass Spectrometry [ PDF / 364.76KB ]

Characterization of Insoluble Subvisible Particles in Biopharmaceuticals by Flow Imaging Method - Powder Property Analysis [ PDF / 1.43MB ]

Optimizing Aggregate Analysis – Pore Size [ PDF / 311.24KB ]

Peptide Mapping of Monoclonal Antibody (mAb) Using Nexera Bio with Q-TOF Mass Spectrometer for Full Sequence Confirmation - Biopharma / Nexera Bio & Q-TOF LCMS-9030 [ PDF / 2.29MB ]

LCMS™ Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL - Part 7 - Tocilizumab Analysis - - nSMOL Antibody BA Kit [ PDF / 451.79KB ]

Verification of Quantitativity and Confirmation of Molecular Weight of Oligonucleotide therapeutics Using LCMS™-8060 - Liquid Chromatography Mass Spectrometry [ PDF / 222.79KB ]

Peptide Mapping of Monoclonal Antibody (mAb) Using LCMS™-9030 (Q-TOF) Mass Spectrometer with a Shim-pack™ GISS-HP Column - Biopharma / LCMS-9030 (Q-TOF) [ PDF / 590.74KB ]

Disulfide Bond Characterization of Monoclonal Antibody (mAb) Using Q-TOF Mass Spectrometer - Biopharma / LCMS-9030 (Q-TOF) [ PDF / 400.05KB ]

Monoclonal Antibody Workflows on the Shimadzu Q-TOF LCMS-9030 Using the Protein Metrics Software Suite - Liquid Chromatography Mass Spectrometry [ PDF / 1.49MB ]

Direct Analysis of Metallic Elements in Cell Culture Medium by Atomic Absorption Spectrophotometry (AAS) [ PDF / 242.94KB ]

In-depth Peptide Mapping of Monoclonal Antibody (mAb) by A de novo Peptide Sequencing Method on Q-TOF Mass Spectrometer with Data-independent Acquisition [ PDF / 423.05KB ]

N-glycan Profiling of monoclonal Antibody (mAb) on Nexera Bio UHPLC Coupled with Fluorescence Detector and Q-TOF Mass Spectrometer [ PDF / 594.15KB ]

Characterization of C-terminal and Disulfide Bond Peptides of Monoclonal Antibody (mAb) on Q-TOF Mass Spectrometer [ PDF / 1.09MB ]

Bioanalytical assessment of Cetuximab in Wistar rat plasma using nSMOL and LCMS-8060 [ PDF / 807.83KB ]

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 4 - - Multiplex Analysis - [ PDF / 616.77KB ]

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - - Nivolumab analysis - [ PDF / 1.15MB ]

Quantitative Analysis and Determination of Molecular Weight of siRNA Type Oligonucleotides by LCMS™-8060 - Liquid Chromatography Mass Spectrometry [ PDF / 263.27KB ]

Optimizing Aggregates Analysis – Mobile Phase [ PDF / 513.30KB ]

N-Terminal Amino Acid Sequencing of IgG Antibodies - Protein Sequencer [ PDF / 110.74KB ]

A comprehensive N-Glycan Profiling Analysis of Bevacizumab Biosimilar by UHPLC with Fluorescence Detection and Q-TOF Mass Spectrometry - ThP 486 [ PDF / 384.83KB ]

Analysis of N-Terminal Amino Acid Sequence of Monoclonal Antibody Using the MALDI-7090 High-Resolution MALDI-TOF MS [ PDF / 898.60KB ]

Qualitative Characterization and Quantitative Assessment of Monoclonal Antibodies Using Protein Metrics and nSMOLcoupled with the Shimadzu LCMS-9030 QTOF [ PDF / 887.94KB ]

Characterization of Monoclonal Antibody Biosimilar through C-terminal and Disulfide Bond Peptides Sequencing Analysis on Q-TOF Mass Spectrometer [ PDF / 957.83KB ]

Charge Variant analysis of mAb Biosimilars by Nexera™ UHPLC with a Shim-pack™ Bio IEX Column [ PDF / 191.03KB ]

Analysis of mAb Aggregates by Nexera™Bio UHPLC with a Shim-pack™Bio Diol (Size Exclusion) Column - Biopharma / Nexera Bio UHPLC [ PDF / 170.10KB ]

A Single Injection LC-MS Analysis Scheme for Simultaneous Analysisof Biotherapeutics and Host-Cell Impurities via Online Digestion LC-MS/MS [ PDF / 494.45KB ]

Development of MRM Methods for Monoclonal Antibodies Using Skyline [ PDF / 1.57MB ]

Analysis of Fatty Acid Content Ratios in Polysorbate 80 [ PDF / 832.42KB ]

LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy – - nSMOLTM Antibody BA Kit [ PDF / 204.08KB ]

LCMS Bioanalysis of Antibody Drugs Using Fabselective Proteolysis "nSMOL Method" - Part 6 - Improvement of Reaction Conditions for Automated Analyses - - nSMOLTM Antibody BA Kit [ PDF / 72.76KB ]

Determination of Molecular Mass and Quantification of Oligonucleotide Therapeutics Using Quadrupole Time-of-Flight Mass Spectrometer LCMS™-9030 - LC-MS [ PDF / 132.47KB ]

Solutions for Biopharmaceutical [ PDF / 16.14MB ]

Maldi 3: Optimised sample preparation for the MALDI Tof-MS Oligonucleotides [ PDF / 180.55KB ]

High Mass MALDI-TOF MS Strategy for Antibody Aggregate Characterization [ PDF / 1.66MB ]

Direct Swab' TOC of E. Coli cells in biopharmaceutical cleaning validation [ PDF / 2.67MB ]

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 2 - - Bevacizumab analysis - [ PDF / 620.70KB ]